| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 59.95M (14.35%) | -1.90M Decreased by -3.17% | Jun 30, 25 |
| 2 | FMR Inc | 55.51M (13.29%) | 3.84M Increased by +6.92% | Jun 30, 25 |
| 3 | Morgan Stanley - Brokerage Accounts | 44.69M (10.70%) | 8.77M Increased by +19.62% | Jun 30, 25 |
| 4 | BlackRock Inc | 40.32M (9.65%) | -1.34M Decreased by -3.33% | Jun 30, 25 |
| 5 | Vanguard Group Inc | 39.33M (9.42%) | -1.44M Decreased by -3.66% | Jun 30, 25 |
| 6 | Viking Global Investors LP | 34.24M (8.20%) | -11.78M Decreased by -34.39% | Jun 30, 25 |
| 7 | Qvt Financial LP | 29.38M (7.03%) | -36.41M Decreased by -123.93% | Jun 30, 25 |
| 8 | Rubric Capital Management LP | 20.37M (4.88%) | 2.60M Increased by +12.78% | Jun 30, 25 |
| 9 | State Street Corp | 19.77M (4.73%) | 911.83K Increased by +4.61% | Jun 30, 25 |
| 10 | State Street Corporation | 17.15M (4.11%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 11 | Wellington Management Company LLP | 13.64M (3.27%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 12 | Patient Square Capital | 12.48M (2.99%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 13 | T. Rowe Price Investment Management,Inc. | 10.65M (2.55%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 14 | Two Seas Capital LP | 10.60M (2.54%) | 461.73K Increased by +4.36% | Jun 30, 25 |
| 15 | Amvescap Plc. | 9.88M (2.37%) | 365.47K Increased by +3.70% | Mar 31, 25 |
| 16 | Dimensional Fund Advisors, Inc. | 7.89M (1.89%) | 5.30M Increased by +67.18% | Jun 30, 25 |
| 17 | Geode Capital Management, LLC | 7.75M (1.86%) | -216.99K Decreased by -2.80% | Jun 30, 25 |
| 18 | Farallon Capital Management, L.L.C. | 7.34M (1.76%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| 19 | Citadel Advisors Llc | 5.93M (1.42%) | 4.00M Increased by +67.54% | Sep 30, 24 |
| 20 | Goldman Sachs Group Inc | 5.39M (1.29%) | 1.19M Increased by +22.09% | Sep 30, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 26.16M (6.26%) | 990.65K Increased by +3.79% | Jul 31, 25 |
| 2 | Fidelity Growth Compy Commingled Pl O | 21.15M (5.06%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 3 | Fidelity Growth Company Fund | 19.18M (4.59%) | 557.44K Increased by +2.91% | Jul 31, 25 |
| 4 | Vanguard US Total Market Shares ETF | 14.26M (3.42%) | 14.26M Increased by +100.00% | Sep 30, 24 |
| 5 | iShares Core S&P Mid-Cap ETF | 13.70M (3.28%) | 0.00 Increased by 0.00% | Aug 31, 25 |
| 6 | Vanguard Total Stock Mkt Idx Inv | 13.12M (3.14%) | -274.00K Decreased by -2.09% | Jul 31, 25 |
| 7 | Fidelity® Growth Company | 10.84M (2.60%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Small Cap Index | 9.90M (2.37%) | -71.12K Decreased by -0.72% | Jul 31, 25 |
| 9 | Vanguard Health Care Inv | 9.57M (2.29%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 10 | SPDR® S&P Biotech ETF | 7.21M (1.73%) | 16.07K Increased by +0.22% | Aug 31, 25 |
| 11 | Invesco S&P MidCap Quality ETF | 6.02M (1.44%) | 0.00 Increased by 0.00% | May 30, 25 |
| 12 | Fidelity Growth Company K6 | 5.68M (1.36%) | 272.81K Increased by +4.81% | Jul 31, 25 |
| 13 | Vanguard Small Cap Growth Index Inv | 5.57M (1.33%) | -22.41K Decreased by -0.40% | Jul 31, 25 |
| 14 | T. Rowe Price Mid-Cap Growth | 5.25M (1.26%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 15 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (1.26%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 16 | Fidelity Series Growth Company | 5.04M (1.21%) | 95.50K Increased by +1.89% | Jul 31, 25 |
| 17 | Fidelity® Select Biotechnology | 4.60M (1.10%) | 61.10K Increased by +1.33% | Nov 30, 23 |
| 18 | Vanguard Institutional Extnd Mkt Idx Tr | 4.52M (1.08%) | -1.98M Decreased by -43.88% | Jul 31, 25 |
| 19 | MS INVF US Growth I | 4.03M (0.97%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 20 | MS INVF US Advantage I | 3.77M (0.90%) | 0.00 Increased by 0.00% | Jun 30, 25 |